Clinical Trial Update: Effect of Inhalatory Sedation in Subarachnoid Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating inhalatory sedation in patients with subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Subarachnoid Hemorrhage

Snippet

Sponsor: A.O.U. Città della Salute e della Scienza | Conditions: Subarachnoid Hemorrhage, Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Status: COMPLETED